Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil-PPC Inc.

Division of Johnson & Johnson
www.jnj.com

Latest From McNeil-PPC Inc.

J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge

J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.

Consumer Legal Issues

J&J Argument Against Liver Damage Experts 'Borders On Ridiculous' – Judge

J&J fails in request to exclude two experts for the plaintiff in bellwether litigation alleging liver damage from indicated doses of Tylenol Extra Strength. The decision represents the second blow in less than a month in J&J's efforts to exclude plaintiff's evidence from the trial.

Consumer Legal Issues

Children's Motrin Label Ruling Shows 'Genuine Confusion' On Pre-emption – J&J

J&J's attorneys argue that a state court ruling of inadequate warnings on Children's Motrin labels conflicts with a federal appellate court's ruling about the product that also swung on whether a manufacturer can be held liable for failing to include a label warning without “clear evidence” FDA would have approved the label.

Consumer BioPharmaceutical

Children's Motrin Label Ruling Shows 'Genuine Confusion' On Pre-emption – J&J

J&J's attorneys argue that a state court ruling of inadequate warnings on Children's Motrin labels conflicts with a federal appellate court's ruling about the product that also swung on whether a manufacturer can be held liable for failing to include a label warning without “clear evidence” FDA would have approved the label.

Consumer BioPharmaceutical
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register